Advances in Tissue and Organ Replacement

被引:39
作者
Atala, Anthony [1 ]
机构
[1] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA
关键词
Acellular tissue matrices; Bladder; Cartilage; Collagen implants; Extracellular matrix; Polymer;
D O I
10.2174/157488808783489435
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Applications of regenerative medicine technology may offer new therapies for patients with injuries, end-stage organ failure, or other clinical problems. Currently, patients suffering from diseased and injured organs can be treated with transplanted organs. However, there is a shortage of donor organs that is worsening yearly as the population ages and new cases of organ failure increase. Scientists in the field of regenerative medicine and tissue engineering are now applying the principles of cell transplantation, material science, and bioengineering to construct biological substitutes that will restore and maintain normal function in diseased and injured tissues. The stem cell field is a rapidly advancing aspect of regenerative medicine as well, and new discoveries here create new options for this type of therapy. For example, therapeutic cloning, in which the nucleus from a donor cell is transferred into an enucleated oocyte in order to extract pluripotent embryonic stem cells from the resultant embryo, provides another source of cells for cell-based tissue engineering applications. While stem cells are still in the research phase, some therapies arising from tissue engineering endeavors have already entered the clinical setting, indicating that regenerative medicine holds promise for the future.
引用
收藏
页码:21 / 31
页数:11
相关论文
共 137 条
[1]  
AEBISCHER P, 1987, LIFE SUPPORT SYST, V5, P159
[2]   Renal therapy using tissue-engineered constructs and gene delivery [J].
Amiel, GE ;
Yoo, JJ ;
Atala, A .
WORLD JOURNAL OF UROLOGY, 2000, 18 (01) :71-79
[3]   Current and future modalities for functional renal replacement [J].
Amiel, GE ;
Atala, A .
UROLOGIC CLINICS OF NORTH AMERICA, 1999, 26 (01) :235-+
[4]  
[Anonymous], BIOCOMPATIBILITY CLI
[5]   Insulin production by human embryonic stem cells [J].
Assady, S ;
Maor, G ;
Amit, M ;
Itskovitz-Eldor, J ;
Skorecki, KL ;
Tzukerman, M .
DIABETES, 2001, 50 (08) :1691-1697
[6]   Tissue-engineered autologous bladders for patients needing cystoplasty [J].
Atala, A ;
Bauer, SB ;
Soker, S ;
Yoo, JJ ;
Retik, AB .
LANCET, 2006, 367 (9518) :1241-1246
[7]   A novel inert collagen matrix for hypospadias repair [J].
Atala, A ;
Guzman, L ;
Retik, AB .
JOURNAL OF UROLOGY, 1999, 162 (03) :1148-1150
[8]   FORMATION OF UROTHELIAL STRUCTURES INVIVO FROM DISSOCIATED CELLS ATTACHED TO BIODEGRADABLE POLYMER SCAFFOLDS INVITRO [J].
ATALA, A ;
VACANTI, JP ;
PETERS, CA ;
MANDELL, J ;
RETIK, AB ;
FREEMAN, MR .
JOURNAL OF UROLOGY, 1992, 148 (02) :658-662
[9]   IMPLANTATION IN-VIVO AND RETRIEVAL OF ARTIFICIAL STRUCTURES CONSISTING OF RABBIT AND HUMAN UROTHELIUM AND HUMAN BLADDER MUSCLE [J].
ATALA, A ;
FREEMAN, MR ;
VACANTI, JP ;
SHEPARD, J ;
RETIK, AB .
JOURNAL OF UROLOGY, 1993, 150 (02) :608-612
[10]   INJECTABLE ALGINATE SEEDED WITH CHONDROCYTES AS A POTENTIAL TREATMENT FOR VESICOURETERAL REFLUX [J].
ATALA, A ;
CIMA, LG ;
KIM, W ;
PAIGE, KT ;
VACANTI, JP ;
RETIK, AB ;
VACANTI, CA .
JOURNAL OF UROLOGY, 1993, 150 (02) :745-747